Teladoc’s $18.5B merger with Livongo
–Authored by Xueyiting Wang, King’s College London Overview of the deal Acquirer: Teladoc Health Target: Livongo Estimated Value: $18.5B Announced Date: 8/5/2020 Closed Date: 10/30/2020 Transaction Advisor(s): Lazard served as exclusive financial advisor to Teladoc Health and Paul, Weiss, Rifkind, Wharton & Garrison LLP served as legal advisor. Morgan Stanley served as exclusive financial advisor …